OTC; OTC switch; Rx-to-OTC switch; reclassification; Germany; physicians; pharmacies; patients; stakeholder; community pharmacy; PDE5-Inhibitors

OTC switch of phosphodiesterase-5 inhibitors

By: Nora Krogull, Andrea Stippler, Niels Eckstein, Elmar Kroth. OTC switch of phosphodiesterase-5 inhibitors. SelfCare 2022;13(2)7-15.

View Article